Use of Smoking Cessation Methods among Patients Receiving Office-based Buprenorphine Maintenance Treatment

Pooja A. Shah, Chinazo O. Cunningham, Mia T. Brisbane, Joseph P. DeLuca, Shadi Nahvi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7% were current cigarette smokers, 7.9% were former smokers, and 4.4% had never smoked. Of lifetime smokers, 83.1% reported at least 1 prior quit attempt, and 78.5% had used medication (75.4% used nicotine replacement therapy, 29.2% varenicline, and 9.2% bupropion). Ten patients (15.4%) reported using electronic cigarettes to try to quit smoking. Stopping "cold Turkey" (40.0%) and gradually decreasing the number of cigarettes smoked (32.3%) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.

Original languageEnglish (US)
Pages (from-to)494-497
Number of pages4
JournalJournal of Addiction Medicine
Volume11
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Buprenorphine
Smoking Cessation
Smoking
Withholding Treatment
Therapeutics
Tobacco Products
Community Health Centers
Bupropion
Tobacco Use
Nicotine
Counseling
Cross-Sectional Studies
Drug Therapy

Keywords

  • buprenorphine
  • community health center
  • nicotine use disorder
  • opioid use disorder
  • smoking cessation

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Use of Smoking Cessation Methods among Patients Receiving Office-based Buprenorphine Maintenance Treatment. / Shah, Pooja A.; Cunningham, Chinazo O.; Brisbane, Mia T.; DeLuca, Joseph P.; Nahvi, Shadi.

In: Journal of Addiction Medicine, Vol. 11, No. 6, 01.01.2017, p. 494-497.

Research output: Contribution to journalArticle

@article{cefdb5b917654a8580ccf1be89b0a737,
title = "Use of Smoking Cessation Methods among Patients Receiving Office-based Buprenorphine Maintenance Treatment",
abstract = "Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7{\%} were current cigarette smokers, 7.9{\%} were former smokers, and 4.4{\%} had never smoked. Of lifetime smokers, 83.1{\%} reported at least 1 prior quit attempt, and 78.5{\%} had used medication (75.4{\%} used nicotine replacement therapy, 29.2{\%} varenicline, and 9.2{\%} bupropion). Ten patients (15.4{\%}) reported using electronic cigarettes to try to quit smoking. Stopping {"}cold Turkey{"} (40.0{\%}) and gradually decreasing the number of cigarettes smoked (32.3{\%}) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.",
keywords = "buprenorphine, community health center, nicotine use disorder, opioid use disorder, smoking cessation",
author = "Shah, {Pooja A.} and Cunningham, {Chinazo O.} and Brisbane, {Mia T.} and DeLuca, {Joseph P.} and Shadi Nahvi",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/ADM.0000000000000356",
language = "English (US)",
volume = "11",
pages = "494--497",
journal = "Journal of Addiction Medicine",
issn = "1932-0620",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Use of Smoking Cessation Methods among Patients Receiving Office-based Buprenorphine Maintenance Treatment

AU - Shah, Pooja A.

AU - Cunningham, Chinazo O.

AU - Brisbane, Mia T.

AU - DeLuca, Joseph P.

AU - Nahvi, Shadi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7% were current cigarette smokers, 7.9% were former smokers, and 4.4% had never smoked. Of lifetime smokers, 83.1% reported at least 1 prior quit attempt, and 78.5% had used medication (75.4% used nicotine replacement therapy, 29.2% varenicline, and 9.2% bupropion). Ten patients (15.4%) reported using electronic cigarettes to try to quit smoking. Stopping "cold Turkey" (40.0%) and gradually decreasing the number of cigarettes smoked (32.3%) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.

AB - Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7% were current cigarette smokers, 7.9% were former smokers, and 4.4% had never smoked. Of lifetime smokers, 83.1% reported at least 1 prior quit attempt, and 78.5% had used medication (75.4% used nicotine replacement therapy, 29.2% varenicline, and 9.2% bupropion). Ten patients (15.4%) reported using electronic cigarettes to try to quit smoking. Stopping "cold Turkey" (40.0%) and gradually decreasing the number of cigarettes smoked (32.3%) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.

KW - buprenorphine

KW - community health center

KW - nicotine use disorder

KW - opioid use disorder

KW - smoking cessation

UR - http://www.scopus.com/inward/record.url?scp=85033798675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033798675&partnerID=8YFLogxK

U2 - 10.1097/ADM.0000000000000356

DO - 10.1097/ADM.0000000000000356

M3 - Article

C2 - 28885300

AN - SCOPUS:85033798675

VL - 11

SP - 494

EP - 497

JO - Journal of Addiction Medicine

JF - Journal of Addiction Medicine

SN - 1932-0620

IS - 6

ER -